A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation

Springer Science and Business Media LLC - Tập 10 Số 1 - Trang 5-18 - 1994
Cheryl Fitzgerald1,2, Wilfried Feichtinger3, J Spona3, Max Elstein1, Frank Lüdicke4, UA Müller4, Charles A. Williams4
1Department of Obstetrics and Gynaecology, University Hospital of South Manchester, UK.
2Hormonlabor, Rudolfinerhaus, and Division of Cellular Endocrinology, Ludwig Boltzmann Institute of Experimental Endocrinology, First Department of Obstetrics and Gynaecology, Vienna University, Vienna, Austria
3Institut für Sterilitatsbetreuning, Vienna, Austria
4Schering AG, Berlin, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

Committee on Safety of Drugs. Combine oral contraceptives. A statement by the committee of safety of drugs. Br Med J. 1970;1:231–2.

Jeffcoate TNA. RCOG Statement on oral contraceptives. Br Med J. 1970;1:293.

Elstein M, Bristow PG, Hewitt KJ, Kirk D, Miller H. Effects of a low oestrogen oral contraceptive on urinary excretion of luteinising hormone and ovarian steroids. Br Med J. 1974;1:11–13.

Boen PGH, Hickling DJ, Killick SR, Coelingh Bennink HJT. A progestogen only pill with desogestrel. Proceedings of European Society of Contraception Congress, Athens; 1992.

Mall-Haefeli M, Werner-Zodrow I, Huber PR, Ederman A. Oral contraception and ovarian function. In: Runnebaum B, Rabe T, Kiesel L, eds. Female contraception. Berlin: Springer-Verlag; 1988: 97–105.

Hoogland HJ, Skouby SK. Ultrasound evaluation of ovarian activity under oral contraceptives. Contraception. 1993;47:583–90.

Pincus GG. Some effects of progesterone and related compounds upon reproduction and early development in mammals. Acta Endocrinol. 1956;Suppl 28:18–36.

Pincus GG. The control of fertility. New York: Academic Press; 1956:217–19.

Rock J, Pincus GG, Garcia CR. Effects of certain nortestosteroids on the human menstrual cycle. Science. 1956;124:891–3.

Pincus GG, Rock J, Garcia CR, Rice Whira E, Pamaqua M, Rodriques I. Fertility control with oral medication. Am J Obstet Gynaecol. 1958;75:1333–46.

Spellacy WN, Kalra PS, Buhi WC, Birk SA. Pituitary and ovarian responsiveness to a graded gonadotrophin releasing factor stimulation test in women using low-estrogen or regular type of oral contraception. Am J Obstet Gynaecol. 1980;137:109–15.

Belaisch-Allart J, Dufetre C, Allart JP, De Monzon J. Comparison of transvaginal and transabdominal ultrasound for monitoring follicular development in an in-vitro fertilisation programe. Hum Reprod. 1991;6:688–9.

Smith SK, Kirkman RJE, Arce BB, McNeilly AS, Loudon NB, Baird DT. The effect of deliberate omission of Trinordial or Microgynon on the hypothalamo-pituitary-ovarian axis. Contraception. 1986;34:513–22.

Landeren BM, Csemiczky G. The effect on follicular growth and luteal function of “Missing the Pill” Contraception. 1988;43:149–59.

Chez RA. Clinical aspects of three new progestogens: desogestrel, gestodene and norgestinate. Am J Obstet Gynaecol. 1989;160:1296–300.

Bracken MB, Hellenbrand KG, Holford PR. Conception delay after oral contraceptive use the effect of oestrogen dose. Fertil Steril. 1990;53:21–7.